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Summary  Midbrain—hindbrain  malformations  (MHM)  may  coexist  with  malformations  of  cor-
tical  development  (MCD).  This  study  represents  a  ﬁrst  attempt  to  investigate  the  spectrum  of
MHM  in  a  large  series  of  patients  with  MCD  and  epilepsy.  We  aimed  to  explore  speciﬁc  associ-
ations  between  MCD  and  MHM  and  to  compare  two  groups  of  patients:  MCD  with  MHM  (wMHM)Developmental and  MCD  without  MHM  (w/oMHM)  with  regard  to  clinical  and  imaging  features.disorders;
Midbrain—hindbrain
Two hundred  and  twenty  patients  (116  women/104  men,  median  age  28  years,  interquar-
tile  range  20—44  years  at  the  time  of  assessment)  with  MCD  and  epilepsy  were  identiﬁed  at
the  Departments  of  Neurology  and  Pediatrics,  Innsbruck  Medical  University,  Austria.  All  under-
went  high-resolution  MRIs  (1.5-T)  between  01.01.2002  and  31.12.2011.  Midbrain—hindbrain
structures were  visually  assessed  by  three  independent  raters.
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MHM  were  seen  in  17%  (38/220)  
signiﬁcantly (p  =  0.004)  in  three  c
tion; category  II  —  to  abnormal  ne
late migration/organization):  MC
(23%) were  more  commonly  assoc
neuronal proliferation  (9%).  Exte
compared  to  those  w/oMHM  (63%  
there  were  higher  rates  of  callos
malities  (52%  vs.  27%;  p  <  0.001).
p  =  0.010)  at  the  time  of  assessm
vs. 12  years;  p  =  0.043)  compared
disability  (71%  vs.  38%;  p  <  0.001),
neurological  deﬁcits  (66%  vs.  47%
The groups  (wMHM  and  w/oMHM
seizure outcome,  seizure  types,  
MHM  in  patients  with  MCD  and  e
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alformations  of  cortical  development  (MCD)  represent  a
ajor cause  of  medically  refractory  epilepsy  in  children
nd adults  (Barkovich  et  al.,  2009;  Fauser  et  al.,  2006;
rsek et  al.,  2008;  Leventer  et  al.,  2010;  Palmini  et  al.,
991). MCD  are  classiﬁed  based  upon  the  step  at  which
euronal development  was  ﬁrst  disrupted:  (I)  abnormal  neu-
onal proliferation,  (II)  abnormal  neuronal  migration,  (III)
bnormal late  migration/cortical  organization  (Barkovich
t al.,  2009).  Increased  or  decreased  proliferation  of
ortical neurons  at  early  stages  of  brain  development
esults in  microcephaly,  macrocephaly,  tuberous  sclerosis,
ocal cortical  dysplasia  (FCD)  type  II  with  balloon  cells,
emimegalencephaly or  dysplastic  tumors  (ganglioglioma,
ysembryoplastic neuroepithelial  tumor)  —  MCD  of  category
. MCD  of  category  II  —  e.g.  periventricular  nodular  het-
rotopia (PNH)  or  subcortical  band  heterotopia  (SBH)  are
aused by  disruption  of  neuronal  migration  from  ventricu-
ar areas,  where  neurons  proliferate,  to  cortical  surface
Barkovich et  al.,  2009).  Polymicrogyria  (PMG),  schizen-
ephaly and  FCD  type  I  represent  MCD  of  category  III  with
berrant late  migration/cortical  organization  (lamination,
yration) (Barkovich  et  al.,  2009).
MCD  may  be  associated  with  other  cerebral  struc-
ural anomalies  such  as  abnormalities  of  hippocampus
Kuchukhidze et  al.,  2010),  corpus  callosum  (Hetts  et  al.,
006) or  midbrain—hindbrain  malformations  (MHM)  (Patel
nd Barkovich,  2002).  These  anomalies  may  determine  clin-
cal presentation  of  patients  with  MCD  and  therefore,  play
n important  role  in  their  management  including  epilepsy
urgery. In  a  recent  study  we  hypothesized,  that  the  underly-
ng pathophysiology  of  the  MCD  could  be  responsible  for  both
CD and  associated  hippocampal  pathology  (Kuchukhidze
t al.,  2010).
MHM represent  a  heterogeneous  group  of  posterior  fossa
nomalies (Patel  and  Barkovich,  2002).  Several  attempts
o classify  MHM  have  been  proposed  based  either  on
orphology, disrupted  developmental  stages  or  genetic
ackground (Barkovich  et  al.,  2009;  D‘Arrigo  et  al.,
005; Demaerel,  2002;  Niesen,  2002;  Patel  and  Barkovich,
B
n
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of  patients.  The  rate  of  patients  wMHM  and  w/oMHM  differed
ategories  of  MCD  (category  I  —  to  abnormal  neuronal  prolifera-
uronal  migration;  and  category  III  —  due  to  abnormal  neuronal
D  due  to  abnormal  neuronal  migration  (31%)  and  organization
iated  with  MHM  compared  to  those  with  MCD  due  to  abnormal
nsive  bilateral  MCD  were  seen  more  often  in  patients  wMHM
vs.  36%;  p  =  0.004).  In  wMHM  group  compared  to  w/oMHM  group
al  dysgenesis  (26%  vs.  4%;  p  <  0.001)  and  hippocampal  abnor-
 Patients  wMHM  were  younger  (median  25  years  vs.  30  years;
ent  and  had  seizure  onset  at  an  earlier  age  (median  5  years
 to  those  w/oMHM.  Patients  wMHM  had  higher  rates  of  learning
 delayed  developmental  milestones  (68%  vs.  35%;  p  <  0.001)  and
;  p  =  0.049)  compared  to  those  w/oMHM.
)  did  not  differ  in  their  response  to  antiepileptic  treatment,
EEG  abnormalities  and  rate  of  status  epilepticus.  Presence  of
pilepsy  is  associated  with  severe  morphological  and  clinical
002;  Sztriha  and  Johansen,  2005;  Utsunomiya  et  al.,
006).
The patterns  of  midbrain—hindbrain  involvement  in
ome MCD,  like  lissencephaly,  have  been  well  documented
Boycott et  al.,  2005;  Hong  et  al.,  2000;  Kato  et  al.,  1999).
HM may  assist  in  classifying  MCD  and  linking  them  with
enetics and  pathology  (Jissendi-Tchofo  et  al.,  2009;  Pisano
t al.,  2012).  Previous  studies  on  series  of  patients  with
HM analyzed  the  spectrum  of  MCD  associated  with  cere-
ellar malformations  (n  =  70)  (Patel  and  Barkovich,  2002),
linical features  of  epilepsy  in  patients  with  MHM  (n  =  10)
Recio et  al.,  2007)  or  disorders  of  cognitive  and  affective
evelopment in  patients  with  MHM  (n  =  27)  (Tavano  et  al.,
007). However,  no  studies  have  explored  the  types  of  MHM
n a  large  and  heterogeneous  cohort  of  patients  with  MCD.
This  study  represents  a  ﬁrst  attempt  to  investigate  the
pectrum of  MHM  in  a  large  series  of  patients  with  MCD
nd epilepsy.  We  also  aimed  to  explore  speciﬁc  associa-
ions between  MCD  and  MHM  and  to  compare  two  groups
f patients:  MCD  with  MHM  (wMHM)  and  MCD  without  MHM
w/oMHM) with  regard  to  clinical  and  imaging  features.
ethods
wo  hundred  and  twenty-eight  patients  with  the  MRI  diag-
osis of  MCD  were  identiﬁed  in  the  database  of  the
epartments of  Neurology  and  Pediatrics,  Innsbruck  Med-
cal University,  Austria.  The  database  included  over  7000
atients with  epilepsy  at  the  time  of  this  analysis.  All
atients had  epilepsy.  They  had  at  least  two  MRIs  between
1.01.2002 and  31.12.2011.  Three  children  underwent
resurgical assessment  and  epilepsy  surgery  at  the  Depart-
ents of  Pediatrics  and  Neurosurgery,  Medical  University
f Vienna,  Austria.  Twelve  patients  were  also  assessed  at
he Department  of  Neurology,  Paracelsus  Medical  University,
alzburg, Austria.
MCD  were  classiﬁed  based  on  nomenclature  proposed  by
Open access under CC BY license.arkovich et  al.  (2005,  2012):  category  I  —  due  to  abnormal
euronal proliferation;  category  II  —  due  to  abnormal  neu-
onal migration  and  category  III  —  due  to  abnormal  neuronal
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sMidbrain—hindbrain  malformations  in  patients  
late  migration/organization.  This  most  widely  used  classi-
ﬁcation of  MCD  is  primary  based  on  imaging  features  of
MCD. However,  it  increasingly  incorporates  genetic,  molec-
ular biological  and  embryological  grounds  of  MCD  reﬂecting
its underlying  neurobiology  (Barkovich  et  al.,  2005,  2012).
Dysembryoplastic neuroepithelial  tumor  and  ganglioglioma
(total n  =  33)  were  also  included  in  the  analysis  under  the
category ‘‘developmental  tumors’’  as  they  are  incorporated
in the  classiﬁcation  of  MCD  (Barkovich  et  al.,  2005,  2012).
Imaging
All  patients  underwent  high-resolution  MRI  (1.5-T)  using  a
standard protocol  which  all  patients  with  epilepsy  undergo
at our  institution.  MRI  sequences  included  T1-weighted
three-dimensional  axial  magnetization  prepared  rapid  gra-
dient echo  (MPRAGE)  images  with  and  without  intravenous
contrast application,  axial  and  coronal  T2-weighted  turbo
spin echo,  T1-weighted  inversion  recovery,  T2-weighted  fast
ﬂuid attenuated  inversion  recovery  (FLAIR)  and  diffusion
weighted sequences.  Coronal  T2-weighted  and  FLAIR  slices
were 3  mm  thick  and  were  acquired  at  90◦ perpendicular  to
the long  axis  of  hippocampus.
Deﬁnition  of  terms,  criteria  for  assignment  to  MHM
and selection  of  a study  population
The  database  of  the  Departments  of  Neurology  and  Pedi-
atrics of  the  Innsbruck  Medical  University  was  screened  for
patients with  MCD  and  epilepsy.  All  MRIs  were  analyzed  ret-
rospectively for  detection  and  categorization  of  MHM  by  two
independent raters:  a  neurologist  (GK)  experienced  in  neu-
roimaging of  patients  with  MCD  and  a  neuroradiologist  (FK).
Both raters  were  blinded  for  the  clinical  information  (except
for the  knowledge  that  all  patients  had  MCD  and  epilepsy).
Midbrain,  pons,  medulla,  cerebellar  vermis  and  hemi-
spheres were  visually  assessed  for  size  and  morphology.
Diminished size  of  the  aforementioned  structures  reﬂected
hypoplasia (Fig.  1).  The  grade  of  involvement  was  further
delineated as  mild,  severe  or,  in  case  of  vermis—inferior
vermian hypoplasia  (Table  1).  Dysplasia  was  considered  if
the midbrain—hindbrain  structure  was  distorted  and  disor-
ganized, if  abnormal  cerebellar  (hemispheric  or  vermian)
foliation and  ﬁssures  were  present  (Fig.  2).  For  statistical
analysis, MHM  were  divided  into  hypoplasia  and  dyspla-
sia. MHM  was  attributed  to  either  category  (hypoplasia  or
dysplasia) if  at  least  one  of  the  posterior  fossa  structures
(midbrain, pons,  medulla,  cerebellar  vermis  and  hemi-
spheres) was  either  hypoplastic  or  dysplastic.  In  cases,  when
hypoplasia and  dysplasia  of  different  posterior  fossa  struc-
tures coexisted,  MHM  was  categorized  as  dysplastic.
MHM  were  classiﬁed  into  conventional  categories  (e.g.
Rhombencephalosynapsis),  whenever  possible.
The  cerebellum  was  regarded  atrophic  if  it  was  diffusely
small, shrunken  with  large  ﬁssures  and  if  it  underwent  pro-
gressive volume  loss  over  time  (Patel  and  Barkovich,  2002).
Agreement  between  the  two  raters  (GK,  FK)  was  reached
in 214/228  cases  (Cohen’s  kappa  coefﬁcient,    =  0.842,
p <  0.0001).
Four  out  of  228  patients  were  excluded  from  the  fur-
ther analysis  as  they  had  progressive  cerebellar  atrophy
e
t
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documented  at  least  on  two  sequential  MRIs),  which  was
ttributed to  the  longstanding  use  of  phenytoin.
In  214  out  of  remaining  224  patients,  181  had  normal
idbrain—hindbrain structures,  and  33  patients  had  MHM.  In
0/224 disputed  cases,  a  third  evaluator,  a  neuroradiologist
rom another  institution  (SF),  also  blinded  for  clinical  infor-
ation, was  consulted.  The  decision  was  made  with  two  out
f  three  votes:  one  out  of  ten  patients  was  regarded  as  hav-
ng normal  midbrain—hindbrain  structures,  ﬁve  out  of  ten  —
HM, four  out  of  ten  patients  were  excluded  from  the  study
ue to  three  different  opinions.
Eventually,  220  patients  were  included  in  the  study;
8/220 patients  were  considered  having  MHM;  182/220  —
ot having  MHM.
Microcephaly was  diagnosed  in  patients  with  head  cir-
umference remaining  proportionately  small  with  age  and
anging between  −4  and  −12  standard  deviation  from  the
ean.
Hippocampal abnormalities  were  deﬁned  based  on  a  cat-
gorization proposed  by  our  group  (Kuchukhidze  et  al.,
010):
Partially infolded/hypoplastic  hippocampus:  incom-
letely infolded  or  unfolded,  vertically  oriented,  excessively
hin hippocampus  with  distorted  anatomy,  missing  internal
tructure, without  signal  change  in  T2  and  FLAIR  sequences.
Hippocampal  sclerosis:  atrophic  hippocampus  with  miss-
ng internal  structure,  increased  signal  in  T2  and  FLAIR
equences.
Malrotated hippocampus:  abnormally  round,  globular-
haped or  pyramidal,  vertically  oriented  rather  than  ovoid,
ncompletely rotated  hippocampus  without  signal  change  in
2 and  FLAIR  sequences.  Additional  criteria  were  steep  angle
f collateral  sulcus  and  particular  triangular  conﬁguration  of
emporal horn  (normal  collateral  sulcus  angle  is  ﬂat  at  the
evel of  tale  and  body  of  hippocampus).
Enlarged  hippocampus:  hyperplastic  hippocampus  with
istorted anatomy,  missing  internal  structure  and  increased
ignal in  T2  and  FLAIR  sequences.
Corpus  callosum  was  assessed  visually.  Dysgenesis  of  cor-
us callosum  was  considered  if  it  was  either  entirely  or
artially absent.
atients
ata  of  220  patients  (116  women/104  men,  median  age
8 years,  interquartile  range  20—44  years  at  the  time  of
ssessment) were  retrospectively  analyzed.  Diagnosis  of
CD was  based  on  MRI  in  all  patients.  Patients  with  intelli-
ence quotient  (IQ)  lower  than  70  were  classiﬁed  as  learning
isabled. Seizure  types  and  epilepsy  syndromes  were  classi-
ed according  to  nomenclature  of  the  International  League
gainst Epilepsy  (1981,  1989).
tatistics
ategorical  data  were  analyzed  by  means  of  2  ×  2  Chi-
quare test  with  Yates  correction.  Either  Freeman-Halton
xtension of  Fisher’s  exact  probability  test  or  Chi-square
est with  Yates  correction  were  used  for  tables  larger  than
 ×  2.  In  case  of  signiﬁcant  differences,  paired-wise  com-
arisons were  carried  out  by  means  of  2  ×  2  Fisher’s  exact
184  G.  Kuchukhidze  et  al.
Figure  1  Cerebellar  hypoplasia.  First  column  (A1—4)  —  severe  cerebellar  hypoplasia.  (A1)  Axial  T1-weighted  image  shows  micro-
cephaly,  (A2)  coronal  T1  —  weighted  image  shows  enlarged  posterior  fossa  (white  arrow)  with  severely  hypoplastic  vermis  and
cerebellar  hemispheres,  (A3)  T1-weighted  axial  image  with  large  posterior  fossa  cerebro-spinal  ﬂuid  (CSF)  collection  (black  arrow),
(A4)  midline  sagittal  T2-weighted  image  shows  enlarged  IV  ventricle,  large  collection  of  CSF  in  posterior  fossa  (asterisk)  and  hypoplas-
tic  vermis.  Second  column  (B1—4)  —  isolated  hypoplasia  of  cerebellar  vermis.  (B1)  Asterisks  show  subcortical  band  heterotopia  on
T1-weighted  axial  image;  coronal  T2-weighted  (B2)  and  axial  T1-weighted  (B3)  images  show  enlarged  IV  ventricle  (white  arrow)
and  large  collection  of  CSF  in  posterior  fossa  (black  arrow),  (B4)  T1-weighted  sagittal  image  with  hypoplastic  vermis  and  large
collection  of  CSF  in  posterior  fossa  (white  asterisk).  Third  column  (C1—4)  —  severe  hypoplasia  of  brainstem  and  cerebellum.  (C1)
Axial  T2-weighted  image,  periventricular  nodular  heterotopia  on  the  right;  coronal  (C2)  and  axial  (C3)  T2-weighted  images  show
hypoplastic  cerebellar  vermis  with  enlarged  IV  ventricle  and  large  collection  of  CSF  in  posterior  fossa  (white  arrow),  (C4)  atrophic
pons  (black  asterisk),  hypoplastic  vermis  with  enlarged  collection  of  CSF  in  posterior  fossa  (white  asterisk)  and  agenesis  of  corpus
callosum  on  sagittal  T1-weighted  image.
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Table  1  The  patients  with  MHM,  their  spectrum  and  relationship  to  different  MCD.
N  Sex  Agea MCD  category  MCD  type  Midbrain  Medulla  Pons  Vermis  Cerebellar  hemispheres
1  M  32  Proliferation  TS  N  N  N  IVH  N
2  M  23  Proliferation  TS  N  N  N  MH  N
3  W  11  Proliferation  TS  N  N  N  IVH  N
4  W  22  Proliferation  TS  N  N  N  MH  N
5  W  23  Proliferation  TS  N  N  N  N  D
6  M  16  Proliferation  MCRC  N  N  N  MH  MH
7  W  27  Proliferation  MCRC  N  N  N  SH  SH
8  W  8  Proliferation  HMGE  N  N  N  D  D
9  W  24  Proliferation DT  N  N  N  MH  N
10 M  25  Proliferation FCD  II N  N  N  MH  N
11 W  15  Migration  PNH  N  N  N  IVH  N
12 M  24  Migration  PNH  N  N  N  D  D
13 M  33  Migration  PNH  N  N  N  SH  MH
14 M  3  Migration  PNH  MH  N  N  D  D
15 W  29  Migration  PNH  N  N  N  MH  N
16 W  16  Migration  PNH  N  N  N  SH  SH
17 M  15  Migration  PNH  MH  N  N  D  D
18 W  39  Migration  PNH  N  N  N  IVH  N
19 M  39  Migration  PNH  SH  SH  SH  SH  SH
20 W  28  Migration  PNH  SH  SH  SH  SH  SH
21 W  44  Migration  SBH  N  N  N  IVH  N
22 M  11  Organization  PMG  N  N  N  D  D
23 W  11  Organization  PMG  N  N  N  D  D
24 W  30  Organization  PMG  MH  N  N  MH  N
25 M  35  Organization  PMG  MH  N  N  N  N
26 M  27  Organization  PMG  MH  N  N  N  N
27 M  45  Organization  PMG  MH  N  N  N  N
28 M  23  Organization  PMG  N  N  N  SH  MH
29 W  4  Organization  PMG  SH  N  N  N  N
30 W  34  Organization  PMG  MH  N  N  IVH  N
31 W  33  Organization  PMG  N  N  N  D  D
32 W  34  Organization  PMG  N  N  N  D  D
33 M  11  Organization  PMG  SH  MH  N  MH  N
34 W  6  Organization  PMG  N  N  N  MH  MH
35 M  20  Organization  PMG  SH  SH  N  N  N
36 M  34  Organization  PMG  SH  MH  N  MH  N
37 M  45  Organization  FCD  I  N  N  N  MH  N
38 M  47  Organization  FCD  I  N  N  N  D  D
Abbreviations: MHM: midbrain—hindbrain malformation; MCD: malformations of cortical development; W: woman; M: man; DT: devel-
opmental tumor; FCD II: focal cortical dysplasia type II; TS: tuberous sclerosis; MCRC: microcephaly; HMGE: hemimegalencephaly; PNH:
periventricular nodular heterotopia; SBH: subcortical band heterotopia; PMG: polymicrogyria; FCD I: focal cortical dysplasia type I; N:
normal; MH: mild hypoplasia; SH: severe hypoplasia; IVH: inferior vermian hypoplasia; D: dysplasia.
a Age at the time of this analysis.
a
i
d
m
c
dprobability  test  or  2  ×  2  Chi-square  test  with  Yates  cor-
rection. Non-categorical  data  (e.g.,  age  at  seizure  onset)
were ﬁrst  analyzed  by  Kruskal—Wallis  test.  Two-by-two  com-
parisons were  performed  by  means  of  Mann—Whitney  test.
Inter-rater agreement  for  assignment  of  MHM  to  different
categories was  assessed  using  Cohen’s  kappa  coefﬁcient  ().
Signiﬁcance was  set  at  ˛  =  0.05.  There  were  no  missing  data
in the  entire  analysis.
In a  preliminary  data  analysis,  a  series  of  univari-
ate ANCOVA  were  performed  to  investigate  whether
age at  the  time  of  assessment,  age  at  seizure  onset
g
c
n
gnd  response  to  antiepileptic  drugs  were  confound-
ng factors  with  regard  to  clinical  features  (learning
isability, neurological  deﬁcits,  delayed  developmental
ilestones etc.)  when  groups  wMHM  and  w/oMHM  were
ompared.
Multinomial logistic  regression  test  was  performed  to
etermine whether  the  presence  of  bilateral  MCD  and  dys-
enesis of  corpus  callosum  could  be  confounding  factors  for
linical presentation  (epilepsy  syndrome,  learning  disability,
eurological deﬁcit,  developmental  milestones,  etc.)  when
roups wMHM  and  w/oMHM  were  compared.
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Figure  2  Cerebellar  dysplasia.  First  column  (A1—4)  —  rhombencephalosynapsis.  (A1)  Axial  T2-weighted  image  with  bilateral  frontal
polymicrogyria  (asterisk);  (A2)  T2-weighted  coronal  and  (A3)  T1-weighted  axial  images  show  dorsally  fused  cerebellar  hemispheres
and  superior  cerebellar  peduncles;  (A4)  T2-weighted  sagittal  image.  Second  column  (B1—4)  —  cerebellar  polymicrogyria  with  cleft.
(B1)  Axial  T1-weighted  image  with  bilateral  periventricular  nodular  heterotopia  along  temporal  horns  of  lateral  ventricles  (thin
white  arrows);  (B2)  coronal  T2-weighted,  (B3)  axial  T1-weighted  and  (B4)  sagittal  T1-weighted  images  show  irregular  structure  of
cerebellum  in  three  different  planes.  (B2)  Hypoplastic/partially  infolded  hippocampi.  Cleft  with  overlying  polymicrogyria  (thick
white  arrows  in  B3  and  B4)  of  the  right  cerebellar  hemisphere  (right  hemisphere  is  smaller  compared  to  the  left  one).  Third
column  (C1—4)  —  cerebellar  polymicrogyria  with  cleft.  (C1)  subcortical  tubers  on  coronal  FLAIR  image  (white  asterisk);  (C2)  axial
T2-weighted  and  (C3)  T1-weighted  images  show  two  sites  of  cerebellar  polymicrogyria  with  cleft  on  the  right  (white  arrows).  (C4)
sagittal  T1-weighted  image  corresponding  to  the  section  on  axial  T2-weighted  (C2)  and  T1-weighted  (C3)  images  with  a  deep  ﬁssure
and  polymicrogyric  cerebellar  cortex  (white  arrow).
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Mthical  considerations
his  is  a  retrospective  non-invasive  study,  which  does  not
equire ethics  committee  approval  according  to  the  Austrian
aw on  Research.  All  patients  gave  informed  consent  for  an
RI which  was  performed  in  the  framework  of  diagnostic
ork up.
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CD  spectrum  in  the  whole  cohort  (n  = 220)he  most  common  MCD  were  polymicrogyria  (21%),  develop-
ental tumors  (15%),  periventricular  nodular  heterotopias
14%), focal  cortical  dysplasia  type  II  (14%),  focal  cortical
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dysplasia  type  I  (13%)  and  tuberous  sclerosis  (TS)  (10%).  MCD
were bilateral  in  64%  and  unilateral  —  in  36%  of  patients.  MCD
was conﬁned  to  temporal  lobe  in  40%  of  patients.  Hippocam-
pal abnormalities  were  observed  in  31%  and  dysgenesis  of
corpus callosum  —  in  8%  of  patients  with  MCD.  The  clini-
cal spectrum  of  the  patients  was  as  follows:  86%  had  focal
epilepsy (most  common  were  temporal  lobe  —  46%  and  mul-
tifocal —  24%  epilepsies).  Pharmacoresistant  seizures  were
observed in  63%  of  patients;  18%  —  underwent  epilepsy
surgery. Neurological  deﬁcits  were  seen  in  50%;  learning  dis-
ability —  in  44%  and  delayed  developmental  milestones  —  in
40% of  patients.
Midbrain—hindbrain  malformations  (n  =  38)
MHM  were  identiﬁed  in  17%  (38/220)  of  patients  with  MCD
and epilepsy.  Cerebellum  (either  vermis  or  hemispheres,
or both)  was  affected  in  84%  of  patients  with  MHM.  Mild
vermian hypoplasia  was  observed  in  29%,  severe  vermian
hypoplasia —  in  16%,  inferior  vermian  hypoplasia  —  in  16%,
and vermian  dysplasia  —  in  24%  (Table  1).  Cerebellar  hemi-
spheres were  either  dysplastic  (26%)  or  hypoplastic  (mild  —
10%, severe  —  10%)  (Table  1).  Merely  hypoplasia  was  found
in midbrain  (mild  —  18%,  severe  —  16%),  medulla  (mild—5%,
severe —  8%)  and  pons  (severe  —  5%)  (Table  1).
Patients  with  MHM-hypoplasia  and  MHM-dysplasia  did  not
differ with  regard  to  clinical  and  electrophysiological  char-
acteristics.  MHM-hypoplasia  and  MHM-dysplasia  did  not  vary
with respect  to  the  association  with  different  MCD  types,
dysgenesis of  corpus  callosum  and  hippocampal  abnormal-
ities. Among  those  MHM  attributed  to  the  conventional
categories were  cerebellar  polymicrogyria  with  clefts  (n  =  6)
and rhombencephalosynapsis  (n  =  4).
Comparison  of  wMHM  and  w/oMHM  groups
The  data  presented  in  this  section  are  detailed  in  Table  2.
The  rate  of  patients  wMHM  and  w/oMHM  differed  sig-
niﬁcantly (p  =  0.004)  in  three  categories  of  MCD  (category
I —  due  to  abnormal  neuronal  proliferation;  category  II  —
due to  abnormal  neuronal  migration;  and  category  III  —  due
to abnormal  neuronal  late  migration/organization).  Patients
with MCD  of  category  II  (31%)  were  more  commonly  associ-
ated with  MHM  compared  to  those  with  MCD  of  category  I
(9%, p  =  0.004).  Likewise,  there  was  a  strong  link  between
MHM and  MCD  of  category  III  (23%)  compared  to  MCD  of
category I  (9%,  p  =  0.020).  There  was  no  signiﬁcant  differ-
ence with  respect  to  the  rate  of  MHM  when  categories  II
(31%) and  III  (23%)  of  MCD  were  compared.  Patients  wMHM
compared to  those  w/oMHM  had  more  commonly  polymicr-
ogyria (39%  vs.  17.5%,  p  =  0.003)  and  periventricular  nodular
heterotopias (26%  vs.  11%,  p  =  0.012).  Patients  wMHM  versus
those w/oMHM  were  less  frequently  associated  with  devel-
opmental tumors  (3%  vs.  17%,  p  =  0.019)  and  focal  cortical
dysplasia type  II  (3%  vs.  16%,  p  =  0.026).
Patients  wMHM  had  more  often  extensive  bilateral  MCD
(e.g. bilateral  perisylvian  polymicrogyria,  bilateral  periven-
tricular nodular  heterotopia  located  along  lateral  ventricles)
— 63%  in  comparison  to  those  w/oMHM  —  36%  (p  =  0.004).
Extra-temporal  location  of  MCD  was  more  common  in
patients wMHM  —  79%  compared  to  those  w/oMHM  —  55%
g
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p  =  0.012).  Similarly,  extra-temporal  lobe  epilepsies  were
ore frequent  in  wMHM  patients  —  71%  vs.  those  w/oMHM
 50%  (p  =  0.029).
There  were  higher  rates  of  callosal  dysgenesis  (26%  vs.
%; p  <  0.001)  and  hippocampal  abnormalities  (52%  vs.  27%;
 <  0.001)  in  wMHM  group  compared  to  w/oMHM  group.
atients wMHM  compared  to  those  w/oMHM  had  stronger
ssociation with  bilateral  hippocampal  abnormalities  (39%
s. 13%;  p  <  0.001)  and  hypoplastic/partially  infolded  hip-
ocampus (31%,  vs.  12%;  p  =  0.005).
Patients  wMHM  were  younger  compared  to  those  w/oMHM
median 25  years  vs.  30  years;  p  =  0.010)  at  the  time  of  this
nalysis. Patients  wMHM  compared  to  those  w/oMHM  had  an
arlier age  at  seizure  onset  (median  5  years  vs.  12  years;
 =  0.043).
Patients  wMHM  compared  to  those  w/oMHM  had  higher
ates of  learning  disability  (71%  vs.  38%;  p  <  0.001),  delayed
evelopmental milestones  (68%  vs.  35%;  p  <  0.001)  and  neu-
ological deﬁcits  (66%  vs.  47%;  p  =  0.049).
Results  of  a preliminary  data  analysis  (series  of  univariate
NCOVA and  multinomial  logistic  regression  test)  indicated
hat age  at  the  time  of  assessment,  age  at  seizure  onset,
esponse to  antiepileptic  drugs,  presence  of  bilateral  MCD
s well  as  dysgenesis  of  corpus  callosum  were  not  signiﬁ-
ant confounding  factors  with  regard  to  the  rate  of  learning
isability, neurological  deﬁcits  and  delayed  developmental
ilestones when  groups  wMHM  and  w/oMHM  were  com-
ared.
The groups  (wMHM  and  w/oMHM)  did  not  differ  in
heir response  to  antiepileptic  treatment,  seizure  outcome,
eizure types,  EEG  abnormalities  and  rate  of  status  epilep-
icus.
iscussion
n  this  study,  we  aimed  to  investigate  the  spectrum  of  MHM
n patients  with  MCD  and  epilepsy,  to  explore  associations
etween MHM  and  MCD  and  to  compare  clinical  and  imaging
eatures in  two  groups  of  patients:  (i)  with  MCD  and  MHM
nd (ii)  with  MCD  and  without  MHM.
We  report  17%  of  MHM  in  a large  series  of  220  patients
ith MCD  and  epilepsy.  We  found  more  severe  morpholog-
cal (extensive  bilateral  MCD,  hippocampal  abnormalities,
allosal dysgenesis)  and  clinical  (learning  disability,  neu-
ological deﬁcits,  developmental  delay  and  earlier  age  at
eizure onset)  phenotypes  in  patients  with  MHM  and  MCD
ompared to  those  who  had  MCD  without  MHM.
As  hypothesized,  signiﬁcant  differences  were  found  in
ssociation between  MHM  and  various  categories  of  MCD.
HM were  more  commonly  linked  to  the  later  devel-
pmental disorders  —  MCD  due  to  abnormal  neuronal
igration and  abnormal  neuronal  organization  compared
o the  earlier  MCD,  due  to  abnormal  neuronal  prolifera-
ion. This  association  could  be  considered  an  indication
f the  common  pathophysiological  background  of  late
erebral migrational—organizational  disorders  and  MHM.
evelopment of  cerebellum  starts  at  about  four  weeks  of
estation and  extends  to  almost  20  months  of  postnatal  age
Limperopoulos  and  du  Plessis,  2006;  ten  Donkelaar  et  al.,
003). The  migration  of  cerebellar  and  cerebral  cortical  neu-
ons starts  simultaneously  at  about  8th  week  of  gestation
188  G.  Kuchukhidze  et  al.
Table  2  Comparison  of  wMHM  and  w/oMHM  groups.
Demographical  and  clinical  data  wMHM  (n  =  38)  w/oMHM  (n  =  182)  Test  p
Age  in  years,  median  (IQR)  25  (15—34)  30  (20—45)  M—W  0.021
Age  at  seizure  onset  in  years,  median  (IQR)  5  (1—13)  12  (2—17)  M—W  0.043
Sex,  W/M  19/19  97/85  Chi-square  0.841
Epilepsy  syndrome,  TLE/extra-TLE  11/27  91/91  Chi-square  0.029
Seizure  outcome,  seizure  free/not  seizure  free  13/25  69/113  Chi-square  0.806
Status  epilepticus,  yes/no  2/36  13/169  Chi-square  1.0
Focal  slowing  on  EEG,  yes/no 27/11  137/45  Chi-square  0.740
Epileptiform  discharges,  yes/no 23/15  104/78  Chi-square  0.841
AED,  monotherapy/polytherapy 18/20  90/92  Chi-square  1.0
Neurological  deﬁcit,  yes/no 25/13  85/97  Chi-square  0.049
Delayed  milestones,  yes/no  26/12  63/119  Chi-square  <0.001
Learning  disability,  yes/no  27/11  70/112  Chi-square  <0.001
Hippocampal  abnormalities,  yes/no  20/18  49/133  Chi-square  0.004
Dysgenesis  of  corpus  callosum,  yes/no  10/28  7/175  Chi-square  <0.001
MCD  category,  I/II/III  10/11/17  99/25/58  Chi-square  0.004
MCD  Laterality,  unilateral/bilateral  14/24  116/66  Chi-square  0.004
MCD  Location,  temporal/extra-temporal  8/30  81/101  Chi-square  0.012
Tuberous  sclerosis  5/33  18/164  Chi-square  0.548
Microcephaly  2/36  10/172  Chi-square  1.0
Hemimegalencephaly  1/37  9/173  Chi-square  0.532
Developmental  tumors  1/37  32/150  Chi-square  0.019
Focal  cortical  dysplasia  type  II  1/37  30/152  Chi-square  0.026
Periventricular  nodular  heterotopia  10/28  20/162  Chi-square  0.012
Subcortical  band  heterotopia 1/37  3/179  Chi-square  0.680
Lissencephaly  0/38  2/180  N/A  N/A
Polymicrogyria  15/23  32/150  Chi-square  0.003
Focal  cortical  dysplasia  type  I  2/36  26/156  Chi-square  0.129
Abbreviations: wMHM: with midbrain—hindbrain malformation; w/oMHM: without midbrain—hindbrain malformation; IQR: interquartile
range; W: women; M: men; TLE: temporal lobe epilepsy; AED: antiepileptic drugs; M—W: Mann—Whitney-test.
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Signiﬁcant contrasts are marked in bold.
nd  their  organization  and  lamination  continues  into  post-
atal age  (Gleeson  and  Walsh,  2000;  Limperopoulos  and  du
lessis, 2006;  ten  Donkelaar  et  al.,  2003).  The  injury  to
ighly vulnerable  migrating  cells  from  insults  such  as  viruses,
oxins, hemorrhages  may  disturb  subsequent  cerebellar  or
ortical development.  Another  mechanism  leading  to  both,
upratentorial cortical  malformations  and  MHM,  may  be
enetic. Indeed,  a  recent  study  on  midbrain—hindbrain
nvolvement  in  lissencephalies  demonstrated  clear  asso-
iations of  speciﬁc  MHM  phenotypes  with  lissencephaly
ubtypes. The  association  of  lissencephaly  pattern  with
he extent  and  severity  of  midbrain—hindbrain  involvement
ssisted in  predicting  the  mutations  responsible  for  the
evelopmental disorder  (Barkovich  et  al.,  2009;  Jissendi-
chofo et  al.,  2009).
In  our  study,  we  could  not  validate  phenotype-genotype
orrelations  since  only  very  few  of  our  patients  underwent
enetic testing.  However,  our  ﬁndings  may  guide  further
enetic research.
MHM-hypoplasia was  the  most  common  in  our  series
alling in  line  with  another  cross-sectional  retrospective
tudy in  which  Dandy-Walker  malformation,  marked  by
erebellar hypoplasia,  comprised  27%  (19/70)  of  patients
ith cerebellar  malformations  (Patel  and  Barkovich,
002).
o
i
Iles.
Cerebellum  plays  an  important  role  in  cognition.  Patients
ith cerebellar  disorders,  either  congenital  or  acquired,
ay have  cognitive  impairment  (Timmann  and  Daum,  2010).
erebellar malformations  could  be  associated  with  affec-
ive and  social  disorders  as  well  as  neuropsychological
eﬁcits involving  mainly  executive  functions,  visuospa-
ial and  linguistic  abilities  (Tavano  et  al.,  2007).  Motor
eﬁcits are  usually  less  severe  than  cognitive  impairment
n the  patients  with  cerebellar  developmental  malforma-
ions (Tavano  et  al.,  2007).  According  to  our  ﬁndings  learning
isability and  developmental  delay  were  more  frequently
bserved in  patients  wMHM  compared  to  those  w/oMHM.
atients in  the  wMHM  group  had  a  high  frequency  of  bilat-
ral MCD,  which  could  potentially  cause  abnormal  cognitive
tatus (Berg  et  al.,  2009).  However,  in  our  data  analysis,
ilateral MCD  was  not  a  signiﬁcant  confounding  factor  when
ates of  learning  disability  and  developmental  delay  were
ompared in  wMHM  and  w/oMHM  groups.  Higher  rate  of
earning disability  in  our  patients  wMHM  compared  to  those
/oMHM could  not  be  attributed  to  epilepsy  alone,  as  there
as no  difference  between  the  groups  in  terms  of  duration
f epilepsy  and  the  response  to  antiepileptic  drugs.
Dysgenesis  of  corpus  callosum,  which  occurred  frequently
n our  wMHM  group,  is  a  very  heterogeneous  condition.
t could  be  isolated  or  occur  as  a feature  of  numerous
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congenital  syndromes  associated  with  MCD  as  well  as  MHM
(Barkovich and  Norman,  1988;  Tang  et  al.,  2009).  Disorders
of corpus  callosum  present  clinically  with  cognitive  impair-
ment, developmental  delay  and  seizures  (Moes  et  al.,  2009).
In patients  with  callosal  dysgenesis,  hippocampi  are  fre-
quently hypoplastic  as  in  our  series  (Barkovich  and  Norman,
1988). Indeed,  hypoplastic/partially  infolded  hippocampus
(15%, 34/220),  the  commonest  hippocampal  abnormality  in
the whole  series,  which  occurred  bilaterally  in  the  major-
ity of  cases  (91%,  31/34),  was  more  commonly  seen  in
wMHM group  compared  to  w/oMHM  group.  MR  images  of
hypoplastic/partially infolded  hippocampus  resembled  MR
appearance of  hippocampus  at  early  gestational  stages,  sug-
gesting its  developmental  abnormality  (Kier  et  al.,  1997).
The  main  limitation  of  this  study  is  related  to  the  selec-
tion bias  —  we  studied  MHM  in  a  group  of  patients  with  MCD
and epilepsy.  Therefore,  we  cannot  draw  conclusion  on  the
whole spectrum  of  MHM.
Another  shortcoming  of  this  study  is  the  fact  that  MCD
diagnosis was  largely  based  on  MRI  and  histological  conﬁrma-
tion was  available  only  a  relatively  small  proportion  (40/220;
18%) of  patients  who  underwent  epilepsy  surgery.  In  gen-
eral, MCD  could  be  reliably  diagnosed  on  MRI  (Kuzniecky
and Jackson,  2005);  the  most  notorious  for  being  missed
on conventional  MRI  is  FCD  type  I  comprising  about  25%  of
cases in  imaging-histology  correlative  studies  on  large  series
of patients  (Krsek  et  al.,  2008).  In  all  cases  of  FCD  type
I included  in  our  series  (n  =  28),  a  histological  diagnosis  of
postsurgical specimens  was  available.
The  ﬁndings  of  this  study  suggest  that  the  presence  of
MHM in  patients  with  MCD  and  epilepsy  could  be  an  indica-
tor of  a  severe  morphological  and  clinical  phenotype.  Our
results may  have  clinical  implication  with  regard  to  the  sub-
syndrome classiﬁcation  and  may  contribute  to  subsequent
genetic and  basic  research  in  the  ﬁeld.
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